Cartography Biosciences Stock

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.

Sign up today and learn more about Cartography Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Cartography Biosciences Stock

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets.

Funding History

July 2022$57.0M

Management

CEO, Co-Founder

Kevin Parker

Founder

Ansuman Satpathy

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo